LabCorp Venture Fund
In support of LabCorp’s mission to improve health and improve lives, the LabCorp Venture Fund invests in early stage private companies operating in current or strategically adjacent spaces and developing novel solutions to important problems in health and healthcare.
Examples of current and priority investment categories include:
- Novel Diagnostic Tests, Platforms, and Services
- Biomarkers and Companion Diagnostics
- Mobile Health & Digital Diagnostics
- Consumer Wellness, Convenience, and Engagement
- Data-Driven Drug Development and RWE
- Population Health Management and Bioinformatics
- Precision Medicine and CDS
40+
Total Direct Investments
$75-150M
Target Fund Size
Series A-B
Typical Initial Investment